AU2014348901A1 - Devices, systems, and methods for automated medical product or service delivery - Google Patents
Devices, systems, and methods for automated medical product or service delivery Download PDFInfo
- Publication number
- AU2014348901A1 AU2014348901A1 AU2014348901A AU2014348901A AU2014348901A1 AU 2014348901 A1 AU2014348901 A1 AU 2014348901A1 AU 2014348901 A AU2014348901 A AU 2014348901A AU 2014348901 A AU2014348901 A AU 2014348901A AU 2014348901 A1 AU2014348901 A1 AU 2014348901A1
- Authority
- AU
- Australia
- Prior art keywords
- subject
- service
- input
- medical product
- verification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 97
- 229940127554 medical product Drugs 0.000 title claims description 99
- 238000012795 verification Methods 0.000 claims abstract description 80
- 230000036541 health Effects 0.000 claims description 68
- 208000024891 symptom Diseases 0.000 claims description 27
- 230000003862 health status Effects 0.000 claims description 20
- 230000004044 response Effects 0.000 claims description 18
- 238000013475 authorization Methods 0.000 claims description 14
- 230000000007 visual effect Effects 0.000 claims description 11
- 238000005259 measurement Methods 0.000 claims description 7
- 238000012790 confirmation Methods 0.000 claims description 5
- 238000013500 data storage Methods 0.000 claims description 4
- 230000011664 signaling Effects 0.000 claims description 3
- 238000011325 biochemical measurement Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 description 74
- 229940079593 drug Drugs 0.000 description 67
- 239000003814 drug Substances 0.000 description 58
- 230000015654 memory Effects 0.000 description 46
- 230000006854 communication Effects 0.000 description 34
- 238000004891 communication Methods 0.000 description 34
- 238000004590 computer program Methods 0.000 description 27
- 230000008569 process Effects 0.000 description 26
- 238000003860 storage Methods 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 19
- 238000012545 processing Methods 0.000 description 18
- 230000003287 optical effect Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 238000011156 evaluation Methods 0.000 description 13
- 230000005540 biological transmission Effects 0.000 description 12
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 210000003128 head Anatomy 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 230000033001 locomotion Effects 0.000 description 8
- 230000029058 respiratory gaseous exchange Effects 0.000 description 8
- 238000004166 bioassay Methods 0.000 description 7
- 230000005520 electrodynamics Effects 0.000 description 7
- 230000001815 facial effect Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 229940105606 oxycontin Drugs 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 5
- 239000000370 acceptor Substances 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000002483 medication Methods 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 230000003533 narcotic effect Effects 0.000 description 5
- 229960002296 paroxetine Drugs 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 239000010409 thin film Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 description 4
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 4
- 241000545067 Venus Species 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 239000000599 controlled substance Substances 0.000 description 4
- 238000013480 data collection Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 229960002085 oxycodone Drugs 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 229940124641 pain reliever Drugs 0.000 description 4
- 239000000955 prescription drug Substances 0.000 description 4
- 238000002310 reflectometry Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000003044 adaptive effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001430 anti-depressive effect Effects 0.000 description 3
- 239000000935 antidepressant agent Substances 0.000 description 3
- 229940005513 antidepressants Drugs 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000019771 cognition Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000002565 electrocardiography Methods 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 230000008921 facial expression Effects 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 230000005021 gait Effects 0.000 description 3
- 238000005534 hematocrit Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000006855 networking Effects 0.000 description 3
- 238000009597 pregnancy test Methods 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000002207 retinal effect Effects 0.000 description 3
- 201000009032 substance abuse Diseases 0.000 description 3
- 238000001931 thermography Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010004950 Birth mark Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000000094 Chronic Pain Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000012488 Opiate Overdose Diseases 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229940125368 controlled substance Drugs 0.000 description 2
- 238000013479 data entry Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 230000005251 gamma ray Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000005055 memory storage Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 239000000820 nonprescription drug Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 229940005483 opioid analgesics Drugs 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 238000004861 thermometry Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 101100468275 Caenorhabditis elegans rep-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 241001637516 Polygonia c-album Species 0.000 description 1
- 241001272996 Polyphylla fullo Species 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 235000019666 ageusia Nutrition 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 229940124538 antidiuretic agent Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000000701 chemical imaging Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002575 chemical warfare agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000036757 core body temperature Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DWGXUDUOJPYAOR-UHFFFAOYSA-N ditophal Chemical compound CCSC(=O)C1=CC=CC(C(=O)SCC)=C1 DWGXUDUOJPYAOR-UHFFFAOYSA-N 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000008144 emollient laxative Substances 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000012074 hearing test Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000012285 hip pain Diseases 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000003709 image segmentation Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000001566 impedance spectroscopy Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000003331 infrared imaging Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 208000010729 leg swelling Diseases 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000007176 multidirectional communication Effects 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 229960004127 naloxone Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003401 opiate antagonist Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- ZLMJMSJWJFRBEC-OUBTZVSYSA-N potassium-40 Chemical compound [40K] ZLMJMSJWJFRBEC-OUBTZVSYSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- VCBKOGTZQNFBOT-ATZDWAIDSA-N ram-325 Chemical compound C1C(=O)CC[C@@]2(O)[C@H]3CC4=CC=C(OC)C(OC)=C4[C@]21CCN3C VCBKOGTZQNFBOT-ATZDWAIDSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
- G07F17/0092—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for assembling and dispensing of pharmaceutical articles
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Social work or social welfare, e.g. community support activities or counselling services
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F9/00—Details other than those peculiar to special kinds or types of apparatus
- G07F9/001—Interfacing with vending machines using mobile or wearable devices
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F9/00—Details other than those peculiar to special kinds or types of apparatus
- G07F9/009—User recognition or proximity detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- Tourism & Hospitality (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Strategic Management (AREA)
- Theoretical Computer Science (AREA)
- Marketing (AREA)
- Human Resources & Organizations (AREA)
- Economics (AREA)
- Child & Adolescent Psychology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/079,857 US9864842B2 (en) | 2013-11-14 | 2013-11-14 | Devices, systems, and methods for automated medical product or service delivery |
US14/079,778 | 2013-11-14 | ||
US14/079,857 | 2013-11-14 | ||
US14/079,823 US10289806B2 (en) | 2013-11-14 | 2013-11-14 | Devices, systems, and methods for automated medical product or service delivery |
US14/079,778 US20150134345A1 (en) | 2013-11-14 | 2013-11-14 | Devices, systems, and methods for automated medical product or service delivery |
US14/079,823 | 2013-11-14 | ||
PCT/US2014/064848 WO2015073375A1 (fr) | 2013-11-14 | 2014-11-10 | Dispositifs, systèmes et procédés pour la délivrance automatisée de produits ou de services médicaux |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2014348901A1 true AU2014348901A1 (en) | 2016-06-23 |
Family
ID=53057920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2014348901A Abandoned AU2014348901A1 (en) | 2013-11-14 | 2014-11-10 | Devices, systems, and methods for automated medical product or service delivery |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP3069314A4 (fr) |
JP (1) | JP2017501481A (fr) |
KR (1) | KR20160085876A (fr) |
CN (1) | CN105874503A (fr) |
AU (1) | AU2014348901A1 (fr) |
CA (1) | CA2930697A1 (fr) |
WO (1) | WO2015073375A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102014105058A1 (de) * | 2014-04-09 | 2015-10-15 | Stephanie Ittstein | Vorrichtung zu einer Herstellung und/oder zu einer Verabreichung |
FR3061472B1 (fr) * | 2016-12-29 | 2019-10-11 | Arnaud Chaumeil | Securite concernant un engin et une personne equipee d'un dispositif medical |
US11475451B2 (en) | 2017-03-31 | 2022-10-18 | Bayer Healthcare Llc | Biometric authentication for, and secure electronic tracking of, restricted over-the-counter drug sales |
CN107053175A (zh) * | 2017-04-01 | 2017-08-18 | 南京阿凡达机器人科技有限公司 | 一种基于儿童服务机器人的健康管理平台及管理方法 |
US20180293352A1 (en) * | 2017-04-10 | 2018-10-11 | COTA, Inc. | System and Method for Decision-Making for Determining Initiation and Type of Treatment for Patients with a Progressive Illness |
US11031113B1 (en) * | 2017-06-16 | 2021-06-08 | Walgreen Co. | Technology for processing prescription medications for pickup by individuals |
JP2019053511A (ja) * | 2017-09-14 | 2019-04-04 | グローリー株式会社 | 処理システム及び処理管理方法 |
US11636935B2 (en) | 2018-03-02 | 2023-04-25 | Bayer Healthcare Llc | Authenticating, establishing and tracking eligibility of a patient to purchase an over-the-counter drug |
KR101938250B1 (ko) * | 2018-04-04 | 2019-01-14 | 주식회사 큐엠아이티 | 훈련 전/후 상태 정보 기반 부상 예방 시스템, 장치 및 방법 |
CN109147896A (zh) * | 2018-07-20 | 2019-01-04 | 陈宇庆 | 基于多功能药箱的主动健康服务系统 |
EP3866673A4 (fr) * | 2018-10-09 | 2022-09-14 | Inovytec Medical Solutions Ltd. | Système de traitement personnalisé immédiat d'un patient en urgence médicale |
KR102136215B1 (ko) * | 2019-05-16 | 2020-07-21 | 주식회사 어니언스 | 의료기기 관리 방법 및 그 시스템 |
KR20220117651A (ko) | 2021-02-17 | 2022-08-24 | 주식회사 엘브리지 | 건강 상품 주문 및 판매를 위한 모바일 플랫폼 제공 시스템 및 그 운용방법 |
KR20220117650A (ko) | 2021-02-17 | 2022-08-24 | 주식회사 엘브리지 | 키오스크기반 병원 및 요양시설 건강 상품 판매 시스템 |
CN113823373A (zh) * | 2021-10-27 | 2021-12-21 | 云智道智慧医疗科技(广州)有限公司 | 一种眼化学伤智能诊断急救通道系统 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7685026B1 (en) * | 2000-05-05 | 2010-03-23 | Automed Technologies, Inc. | Method of tracking and dispensing medical items |
JP2002032488A (ja) * | 2000-07-14 | 2002-01-31 | Matsushita Electric Ind Co Ltd | 医療情報システム、患者用端末装置、媒体 |
US7870007B1 (en) * | 2002-07-09 | 2011-01-11 | Ncr Corporation | System and method of determining interactions between medicines |
US7087018B2 (en) * | 2002-11-13 | 2006-08-08 | Siemens Medical Solutions Usa, Inc. | System and method for real-time feature sensitivity analysis based on contextual information |
US7616111B2 (en) * | 2005-06-20 | 2009-11-10 | Carestream Health, Inc. | System to monitor the ingestion of medicines |
US7689318B2 (en) * | 2005-08-19 | 2010-03-30 | Lonnie Draper | Inventory control and prescription dispensing system |
US7720569B2 (en) * | 2005-10-25 | 2010-05-18 | Mckesson Automation Systems Inc. | Adaptive interface for product dispensing systems |
US20070106129A1 (en) * | 2005-11-07 | 2007-05-10 | Cardiac Pacemakers, Inc. | Dietary monitoring system for comprehensive patient management |
CA2705151A1 (fr) * | 2007-11-08 | 2009-05-14 | Glaxosmithkline Llc | Systemes et procedes de distribution de produit medical |
US8467897B2 (en) * | 2007-12-19 | 2013-06-18 | Rxsafe Llc | Pharmaceutical storage and retrieval system and methods of storing and retrieving pharmaceuticals |
KR101051263B1 (ko) * | 2009-03-04 | 2011-07-21 | 연세대학교 산학협력단 | 만성질환자를 위한 재택 원격 가정 간호 서비스 시스템 및 방법 |
US8721543B2 (en) * | 2011-01-12 | 2014-05-13 | Arsham Andy Saffarian | Data analytics system |
US9043217B2 (en) * | 2011-03-31 | 2015-05-26 | HealthSpot Inc. | Medical kiosk and method of use |
CN102880776A (zh) * | 2011-07-12 | 2013-01-16 | 李卫云 | 一种物联网医疗系统 |
US9443370B2 (en) * | 2012-03-26 | 2016-09-13 | Omnicare, Inc. | Method and apparatus for onsite distribution of medications and medical supplies |
CN109377668A (zh) * | 2012-04-18 | 2019-02-22 | Jvm有限公司 | 药物配发系统及其控制方法 |
-
2014
- 2014-11-10 KR KR1020167015755A patent/KR20160085876A/ko not_active Application Discontinuation
- 2014-11-10 CA CA2930697A patent/CA2930697A1/fr not_active Abandoned
- 2014-11-10 CN CN201480072246.8A patent/CN105874503A/zh active Pending
- 2014-11-10 WO PCT/US2014/064848 patent/WO2015073375A1/fr active Application Filing
- 2014-11-10 JP JP2016531003A patent/JP2017501481A/ja active Pending
- 2014-11-10 AU AU2014348901A patent/AU2014348901A1/en not_active Abandoned
- 2014-11-10 EP EP14862648.4A patent/EP3069314A4/fr not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP2017501481A (ja) | 2017-01-12 |
CA2930697A1 (fr) | 2015-05-21 |
EP3069314A4 (fr) | 2017-06-14 |
EP3069314A1 (fr) | 2016-09-21 |
WO2015073375A1 (fr) | 2015-05-21 |
CN105874503A (zh) | 2016-08-17 |
KR20160085876A (ko) | 2016-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180089394A1 (en) | Devices, systems, and methods for automated medical product or service delivery | |
US10289806B2 (en) | Devices, systems, and methods for automated medical product or service delivery | |
AU2014348901A1 (en) | Devices, systems, and methods for automated medical product or service delivery | |
US10783989B2 (en) | Devices, systems, and methods for automated data collection | |
US20150134345A1 (en) | Devices, systems, and methods for automated medical product or service delivery | |
US9626650B2 (en) | Cost-effective resource apportionment technologies suitable for facilitating therapies | |
US10528913B2 (en) | Evidence-based healthcare information management protocols | |
US10552581B2 (en) | Evidence-based healthcare information management protocols | |
US20160157735A1 (en) | Techniques for near real time wellness monitoring using a wrist-worn device | |
US10445846B2 (en) | Cost-effective resource apportionment technologies suitable for facilitating therapies | |
US20130173302A1 (en) | Evidence-based healthcare information management protocols | |
CN102880776A (zh) | 一种物联网医疗系统 | |
US10475142B2 (en) | Evidence-based healthcare information management protocols | |
US20130173284A1 (en) | Evidence-based healthcare information management protocols | |
CN202394235U (zh) | 一种物联网医疗系统 | |
US20120265546A1 (en) | Cost-effective resource apportionment technologies suitable for facilitating therapies | |
US20120265547A1 (en) | Cost-effective resource apportionment technologies suitable for facilitating therapies | |
US20130173299A1 (en) | Evidence-based healthcare information management protocols | |
US10559380B2 (en) | Evidence-based healthcare information management protocols | |
US20130173301A1 (en) | Evidence-based healthcare information management protocols | |
US20120265548A1 (en) | Cost-effective resource apportionment technologies suitable for facilitating therapies | |
US10679309B2 (en) | Evidence-based healthcare information management protocols | |
Yang et al. | Enhanced Healthcare System Based on Mobile Communication | |
TR201604967A2 (tr) | Akilli i̇laç kutusu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |